In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy

Author(s):  
Yuxiu Liu ◽  
Qing Liu ◽  
Yingen Liu ◽  
Fuxia Ju ◽  
Qinghua Ma ◽  
...  
Pharmaceutics ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 333 ◽  
Author(s):  
Zhou ◽  
Ichikawa ◽  
Ikeuchi-Takahashi ◽  
Hattori ◽  
Onishi

A novel anionic nanogel system was prepared using succinylated glycol chitosan-succinyl prednisolone conjugate (S-GCh-SP). The nanogel, named NG(S), was evaluated in vitro and in vivo. S-GCh-SP formed a nanogel via the aggregation of hydrophobic prednisolone (PD) moieties and the introduced succinyl groups contributed to the negative surface charge of the nanogel. The resultant NG(S) had a PD content of 13.7% (w/w), was ca. 400 nm in size and had a -potential of −28 mV. NG(S) released PD very slowly at gastric pH and faster but gradually at small intestinal pH. Although NG(S) was easily taken up by the macrophage-like cell line Raw 264.7, it did not decrease cell viability, suggesting that the toxicity of the nanogel was very low. The in vivo evaluation was performed using rats with trinitrobenzene sulfonic acid (TNBS)-induced colitis. NG(S) and PD alone were not very effective at 5 mg PD eq./kg. However, NG(S) at 10 mg PD eq./kg markedly suppressed colonic damage, whereas PD alone did not. Furthermore, thymus atrophy was less with NG(S) than with PD alone. These results demonstrated that NG(S) is very safe, promotes drug effectiveness and has low toxicity. NG(S) has potential as a drug delivery system for the treatment of ulcerative colitis.


2020 ◽  
Vol 2020 ◽  
pp. 1-13
Author(s):  
Dinesh K. Patel ◽  
Yu-Ri Seo ◽  
Sayan Deb Dutta ◽  
Ok Hwan Lee ◽  
Ki-Taek Lim

Maitake (Grifola frondosa) mushroom has received an enormous amount of attention as a dietary supplement due to its high nutritional values. The particle sizes of G. frondosa mushrooms were monitored by a classifying mill. β-Glucans are the bioactive component of the mushroom, and it was revealed through Fourier transform infrared spectroscopy (FTIR), proton and carbon nuclear magnetic resonance (1H and 13C-NMR), matrix-assisted laser desorption/ionization, and time-of-flight (MALDI-TOF) spectrometry. The biocompatibility of G. frondosa particles, as well as induced osteogenesis of hMSCs, was evaluated through WST-1 assay and alizarin staining (ARS) technique, respectively. Notably, enhanced cell viability was noted in the presence of G. frondosa. Significantly improved calcium deposition has observed from hMSCs with G. frondosa, suggesting to their mineralization potential. The expression of osteogenic related gene markers was examined in the presence of G. frondosa through real-time polymerase chain reaction (qPCR) technique. The upregulation of osteogenic gene markers in the presence of G. frondosa particles was indicating their superior osteogenic potential. Besides, G. frondosa also activated the secretion of various kinds of proteins from the hMSCs indicating their potential for tissue engineering applications. Enhanced secretion of different immunoglobulins was observed in rat serum in the presence of G. frondosa, further demonstrating their therapeutic nature. Therefore, G. frondosa is effective for enhanced osteogenesis and can be utilized as a natural, edible, and osteogenic agent.


2016 ◽  
Vol 6 (2) ◽  
pp. 156-164 ◽  
Author(s):  
Inayat Bashir Pathan ◽  
Niteen Subhashrao Misal ◽  
Shripad Bairagi ◽  
Citral Mallikarjuna Setty

2019 ◽  
Vol 50 (1) ◽  
pp. S7
Author(s):  
Marek Pruszynski ◽  
Matthias D’huyvetter ◽  
Magdalena Rodak ◽  
Yana Dekempeneer ◽  
Edyta Cedrowska ◽  
...  

2019 ◽  
Vol 50 (4) ◽  
pp. S73-S74 ◽  
Author(s):  
Marek Pruszynski ◽  
Matthias D’huyvetter ◽  
Magdalena Rodak ◽  
Yana Dekempeneer ◽  
Edyta Cedrowska ◽  
...  

2016 ◽  
Vol 18 (5) ◽  
pp. 1750-1759 ◽  
Author(s):  
Ahmad Bani-Jaber ◽  
Iyad Alshawabkeh ◽  
Samaa Abdullah ◽  
Imad Hamdan ◽  
Adel Ardakani ◽  
...  

2012 ◽  
Vol 27 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Rúbia Menêses da Silva ◽  
Jainara Maria Soares Ferreira ◽  
Cely Dayana Barros da Silva ◽  
Luciana de Barros Correia Fontes ◽  
Ana Flávia Granville-Garcia ◽  
...  

2021 ◽  
Vol 41 (01) ◽  
pp. 25-32
Author(s):  
Zulfia Hussain

Liver diseases are among the major health problems in Pakistan. The present study investigated the mechanism of hepatoprotection by cinnamon, cinnamaldehyde and kaempferol in Acetaminophen (APAP)-induced liver injury. Qualitative phytochemical analysis was performed for standardization of cinnamon ethanolic extract. For in-vivo evaluation, Balb/c mice were administered with cinnamon extract (200 mg/kg i.g.), cinnamaldehyde (10 mg/kg i.g.) and kaempferol (10 mg/kg i.g.) for 14 days followed by administration of APAP (200 mg/kg i.p.). At the end of trial, mice were dissected, and blood, liver and spleen samples were collected for biochemical, histopathological and apoptotic genes expression analysis. Statistical analysis was performed for significance of results. The results showed that the hepatic damage due to APAP administration for 8 hours in mice was apparent with increased severity. Cinnamon extract, cinnamaldehyde and kaempferol pretreatment suggested ameliorative effects on organ injury induced by APAP by decreasing the elevated serum levels of total proteins and bilirubin. In addition, APAP exerted severe alterations on liver histology without affecting spleen histology alongwith upregulation of Bad, Bax and Caspase-3 and downregulation of Bcl-2. However, cinnamon, cinnamaldehyde and kaempferol pretreatment ameliorated APAPinduced liver alterations and apoptosis, possibly through their antioxidant activity. In addition, cinnamaldehyde and kaempferol possessed comparable protective potential at 20-times less dose as compared to cinnamon extract alone, suggesting therapeutic potential at lower dose in APAP-induced liver injury and apoptosis.


Sign in / Sign up

Export Citation Format

Share Document